<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04657549</url>
  </required_header>
  <id_info>
    <org_study_id>Diary number 113/2020</org_study_id>
    <nct_id>NCT04657549</nct_id>
  </id_info>
  <brief_title>Tonsil Surgery in Recurrent or Chronic Tonsillitis</brief_title>
  <official_title>Partial or Total Surgical Removal of Palatal Tonsils to Change Quality of Life for Adults With Chronic or Recurrent Tonsillitis: Pragmatic Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oulu University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tonsil surgery is common in adults with recurrent or chronic tonsillitis. The surgical&#xD;
      techniques include either partial or total surgical removal of the palatal tonsils&#xD;
      (tonsillotomy, TT, and tonsillectomy, TE, respectively). The aim of this study is to find&#xD;
      out, whether tonsil surgery improves the quality of life in these patients and whether the&#xD;
      lighter TT is as effective as TE. Our main outcome is the disease-specific Tonsillectomy&#xD;
      Outcome Inventory-14 (TOI-14) quality of life questionnaire score at 6 months follow-up.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale&#xD;
&#xD;
      Surgical removal of palatal tonsils is among the most common ear, nose and throat operations&#xD;
      in adults in Finland. The vast majority of these operations are done for recurrent and&#xD;
      chronic tonsillitis. Internationally accepted guidelines for the treatment of these diseases&#xD;
      are lacking and the indications for tonsil surgery are practice-based rather than&#xD;
      evidence-based. The choice of the surgical technique further confuses the picture. The&#xD;
      traditional surgical technique has been the total removal of tonsils (tonsillectomy, TE). The&#xD;
      relatively recent introduction of partial resection of tonsils, namely tonsillotomy (TT), is&#xD;
      suggested to have the benefits of less postoperative pain and smaller risk of post-operative&#xD;
      hemorrhage as compared to TE. The relative efficacy of these two techniques to alleviate&#xD;
      infective tonsillar diseases is still unclear.&#xD;
&#xD;
      Objectives&#xD;
&#xD;
      The main aim of this study is to obtain reliable evidence on, whether tonsil surgery improves&#xD;
      the quality of life in adult patients suffering from recurrent or chronic tonsillitis, and&#xD;
      whether the lighter TT would be as effective as TE. We will also compare the scores of a&#xD;
      generic quality of life questionnaire as well as several other subjective and objective&#xD;
      beneficial and harmful outcomes between the groups.&#xD;
&#xD;
      Methods&#xD;
&#xD;
      In this pragmatic multi-center randomized controlled trial, adult patients suffering from&#xD;
      recurrent or chronic tonsillitis will be randomly allocated to three groups: tonsillotomy&#xD;
      group (TT), tonsillectomy group (TE) and control group with watchful waiting (WW) in ratio&#xD;
      2:2:1. The patients in the surgical groups are blinded to the operation type (TT or TE). Our&#xD;
      hypothesis is that both surgical treatments are more effective than watchful waiting in&#xD;
      enhancing quality of life without significant risks (superiority assumption) and that TT is&#xD;
      non-inferior to TE when the surgical groups are compared (non-inferiority assumption). Our&#xD;
      principal outcome is disease-specific quality of life questionnaire score (Tonsillectomy&#xD;
      Outcome Inventory (TOI)-14) at 6 months follow-up. We have validated this questionnaire in&#xD;
      Finnish and explored the interpretation of the scores. Secondary outcomes have been listed in&#xD;
      the Outcomes section.&#xD;
&#xD;
      Separate random allocation lists for the main research center (Oulu University Hospital) and&#xD;
      for the four other centers collectively as well as for recurrent and for chronic tonsillitis&#xD;
      will be used. Random permuted blocks is used with block size varying between 5 and 10. Based&#xD;
      on our earlier study, the principal outcome, TOI-14 score, will most probably be&#xD;
      left-truncated at zero and right-skewed. Therefore, tobit-analysis is used with log (1+y)&#xD;
      transformation. The primary analysis has two phases. Firstly, the TOI-14 score in the&#xD;
      combined surgical group (TT+TE) is compared to that in the WW group. Secondly, the score in&#xD;
      the TT group is compared to that in the TE group. Effects will be estimated by adjusted mean&#xD;
      differences in the log-transformed scores with 95% confidence intervals. Based on our earlier&#xD;
      observational studies on the subject, the following covariates are included in the&#xD;
      multivariable adjusted tobit-model: gender and baseline TOI-14 score together with&#xD;
      stratification factors: enrolling center (Oulu vs. others) and main complaint (recurrent vs.&#xD;
      chronic tonsillitis). In case there is missing data on the primary outcome, a multiple&#xD;
      imputation method will be used. The analyses will be performed on an intention to treat&#xD;
      basis. Per protocol analysis will be performed as sensitivity analysis and results from&#xD;
      comparisons on secondary outcomes and subgroup analysis (main complaint) are used to generate&#xD;
      hypothesis for future trials.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 8, 2020</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients in active arms don't know if they are in tonsillectomy or tonsillotomy group</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Tonsillectomy Outcome Inventory -14 (TOI-14) follow-up score</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>TOI-14 is a disease-specific quality of life questionnaire for throat related symptoms in adults. TOI-14 summary scores vary between 0 and 100 with higher values indicating poorer quality of life. Analysis is described in the Detailed Description section.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>36-Item short Form Survey (SF-36, RAND-36) follow-up score</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in RAND-36 domains scores between groups. RAND-36 instrument produces eight individual values between 0 and 100 (one for each domain), with higher scores indicating better quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion benefiting</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in proportions of patients benefiting clinically significantly from the intervention between the groups (minimum important change in TOI-14 score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days with throat pain</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in the number of days patients have throat pain (severity scaled 0-10) between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days with halitosis</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in the number of days patients have bad breath (severity scaled 0-10) between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days with bleeding</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in the number of days patients have bleeding from the throat (severity scaled 0-10) between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days with tonsil stones</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in the number of days patients have bothering tonsil stones (severity scaled 0-10) between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days with absence from work</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in the number of days patients are absent from work or school due to throat symptoms between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days with dexketoprofen</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in the number of days patients take deksketoprofen 25 mg pain medication due to throat pain between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days with acetaminophen</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in the number of days patients take acetaminophen 1 g pain medication due to throat pain between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days with oxycodone/naloxone</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in the number of days patients take oxycodone/naloxone 5mg/2.5mg pain medication due to throat pain between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical visits</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in the number of medical visit for throat symptoms between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibiotic courses</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in the number of antibiotic courses for throat symptoms between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effect-postoperative bleeding</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Frequency of postoperative bleeding in the surgical groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effect - postoperative pain</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Frequency of postoperative pain in the surgical groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effect - postoperative infection</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Frequency of postoperative infections in the surgical groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effect - dental injury</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Frequency of dental injury in the surgical groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effect -anesthetic complication</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Frequency of anesthetic complication in the surgical groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effect - tightness/globus</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in proportions having feeling of tightness/globus in throat between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effect - voice problems</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in proportions having voice problems between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effect - jaw problems</measure>
    <time_frame>At the end of five to six months follow-up</time_frame>
    <description>Difference in proportions having mandibular joint problems between the groups</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">286</enrollment>
  <condition>Tonsillitis Recurrent</condition>
  <condition>Tonsillitis Chronic</condition>
  <arm_group>
    <arm_group_label>Tonsillectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo tonsillectomy under general anesthesia within three weeks after enrollment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tonsillotomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo tonsillotomy under general anesthesia within three weeks after enrollment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Watchful waiting</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will be closely monitored for the 5-6 months monitoring period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tonsillectomy</intervention_name>
    <description>Tonsillectomy is done by monopolar electrocautery, bipolar scissors or cold instruments. First the mucosa of the anterior palatinal arch is incised and tonsillar capsule identified, then tonsillar tissue is removed along the capsule. Any bleeding is coagulated either with monopolar or bipolar electrocautery.</description>
    <arm_group_label>Tonsillectomy</arm_group_label>
    <other_name>Extracapsular tonsillectomy, ECTE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tonsillotomy</intervention_name>
    <description>Tonsillotomy is done using monopolar electrosurgery, bipolar scissors or coblator device. Most of the tonsillar tissue is removed, exceeding the removal behind the line between anterior and posterior palatinal arch so that only thin layer of tonsil tissue is left over the tonsillar capsule.</description>
    <arm_group_label>Tonsillotomy</arm_group_label>
    <other_name>Intracapsular tonsillectomy, ICTE. Subtotal/intracapsular/partial tonsillectomy, SIPT.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        The inclusion criteria are:&#xD;
&#xD;
          -  Recurrent tonsillitis episodes:&#xD;
&#xD;
               -  At least 4 episodes in the previous 12 months or at least 3 episodes in 6 months&#xD;
&#xD;
               -  Episodes are disabling, prevent normal functioning and are severe enough for the&#xD;
                  patient to seek medical attention&#xD;
&#xD;
               -  Episodes are thought to involve the palatine tonsils based on signs found during&#xD;
                  the episodes (e.g. edema, erythema, exudative tonsillitis, anterior cervical&#xD;
                  lymphadenitis)&#xD;
&#xD;
               -  No throat cultures or antigen/molecular tests to show infection with group A&#xD;
                  streptococcus are needed&#xD;
&#xD;
          -  Chronic tonsillitis:&#xD;
&#xD;
               -  Recurrent or chronic throat pain for at least 6 months&#xD;
&#xD;
               -  At least one symptom or sign that indicate that symptoms originate from the&#xD;
                  palatal tonsils (disturbing tonsil stones, halitosis, anterior cervical&#xD;
                  lymphadenitis, tonsillar exudates, abnormal tonsillar crypts)&#xD;
&#xD;
               -  Symptomatic treatment has not been effective&#xD;
&#xD;
        The exclusion criteria are:&#xD;
&#xD;
          -  Age less than 18 years&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  History of peritonsillar abscess&#xD;
&#xD;
          -  Previous illness that make prompt same-day surgery unfeasible&#xD;
&#xD;
          -  No electronic identity verification tools&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olli-Pekka Alho, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oulu University Hospital, University of Oulu</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aleksi EJ Laajala, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Oulu University Hospital, University of Oulu</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paulus Tokola, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Oulu University Hospital, University of Oulu</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Timo J Autio, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Timo J Koskenkorva, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Oulu</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pasi Ohtonen, M. Sc.</last_name>
    <role>Study Chair</role>
    <affiliation>Division of Operative Care, Oulu University Hospital, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Esa Läärä, PhD.</last_name>
    <role>Study Chair</role>
    <affiliation>Oulu University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aleksi EJ Laajala, MD</last_name>
    <phone>+358505794360</phone>
    <email>aleksi.laajala@ppshp.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paulus Tokola, MD</last_name>
    <phone>+358505794281</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lapland Central Hospital</name>
      <address>
        <city>Rovaniemi</city>
        <state>Lapland</state>
        <zip>FIN-96400</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johanna Mäkinen, MD, PhD</last_name>
      <phone>+358406311598</phone>
    </contact>
    <investigator>
      <last_name>Johanna Mäkinen, MD, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sampo Kujala, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mari Teittinen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Länsi-Pohja Central Hospital</name>
      <address>
        <city>Kemi</city>
        <zip>FIN-94100</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lotta Kristo, MD</last_name>
      <phone>+358401491247</phone>
    </contact>
    <investigator>
      <last_name>Lotta Kristo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emma Alaraudanjoki, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Keski-Pohjanmaa Central Hospital</name>
      <address>
        <city>Kokkola</city>
        <zip>FIN-67200</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annamaria Weitz-Tuoretmaa, MD</last_name>
      <phone>+358406534523</phone>
    </contact>
    <investigator>
      <last_name>Annamaria Weitz-Tuoretmaa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jussi Laranne, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <zip>FIN-90029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aleksi Laajala, MD</last_name>
    </contact>
    <investigator>
      <last_name>Olli-Pekka Alho, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aleksi Laajala, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paulus Tokola, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Timo Autio, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Timo Koskenkorva, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pasi Ohtonen, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Esa Läärä, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mikko Tastula, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seinäjoki Central Hospital</name>
      <address>
        <city>Seinäjoki</city>
        <zip>FIN-60220</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Panu Kuoppala, MD.</last_name>
      <phone>+35864155864</phone>
    </contact>
    <investigator>
      <last_name>Panu Kuoppala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pirjo Rautiainen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sami Pakkala, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Perttu Tavast, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juuso Kujala, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna-Sofia Arponen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lauri Nuutila, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Taneli Kallio, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Laajala A, Autio TJ, Ohtonen P, Alho OP, Koskenkorva TJ. Interpretation of Tonsillectomy Outcome Inventory-14 scores: a prospective matched cohort study. Eur Arch Otorhinolaryngol. 2020 May;277(5):1499-1505. doi: 10.1007/s00405-020-05832-z. Epub 2020 Feb 14.</citation>
    <PMID>32060601</PMID>
  </reference>
  <reference>
    <citation>Koskenkorva T, Koivunen P, Läärä E, Alho OP. Predictive factors for quality of life after tonsillectomy among adults with recurrent pharyngitis: a prospective cohort study. Clin Otolaryngol. 2014 Aug;39(4):216-23. doi: 10.1111/coa.12263.</citation>
    <PMID>24863677</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 16, 2020</study_first_submitted>
  <study_first_submitted_qc>December 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2020</study_first_posted>
  <last_update_submitted>April 1, 2021</last_update_submitted>
  <last_update_submitted_qc>April 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oulu University Hospital</investigator_affiliation>
    <investigator_full_name>Olli-Pekka Alho, MD</investigator_full_name>
    <investigator_title>Professor, MD</investigator_title>
  </responsible_party>
  <keyword>tonsillitis</keyword>
  <keyword>tonsillectomy</keyword>
  <keyword>tonsillotomy</keyword>
  <keyword>tonsil surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tonsillitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Study protocol that includes the Informed Consent Form will be sent to a journal for publication, Statistical analysis Plan will be published later in ClinicalTrials.gov web site.&#xD;
The data generated or analyzed during this study will be available from the corresponding investigator on reasonable request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Study protocol and SAP, will be sent for publication within 12 months from the beginning of recruiting. Data from the study will be available starting six months after publication.</ipd_time_frame>
    <ipd_access_criteria>The data generated or analyzed during this study will be available from the corresponding investigator on reasonable request.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

